Literature DB >> 21232545

Epac-mediated cAMP-signalling in the mouse model of Rett Syndrome.

S L Mironov1, E Y Skorova, S Kügler.   

Abstract

Rett Syndrome (RTT) is a neurodevelopmental disease thought to be caused by deficits in synaptogenesis and neuronal circuitry. cAMP is one of the key factors for neuronal outgrowth, plasticity and regeneration. We examined its homeostasis in RTT during early postnatal development of the essential part of the respiratory network, pre-Bötzinger complex. Using targeted expression of Epac1-camps sensor in neurons we quantified cAMP levels and their fluctuations in MeCP2-/y mice, an established model of RTT. Resting cAMP levels in the mutant were smaller than in the wild-type. cAMP transients elicited by depolarisation and stimulation of adenylate cyclase had also smaller amplitudes and faster time-courses. The anomalies in MeCP2 -/y mice were removed after inhibition of phosphodiesterase PDE4 with rolipram. Brief cAMP elevations triggered elongation of neuronal processes that was significantly bigger in the wild-type. The effects were observed after inhibition of protein kinase A and mimicked by activation of a guanine nucleotide exchange factor, Epac, with 8-(4-Chlorophenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8-pCPT). The agonist reinforced bursting in preBötC neurons in the mutant and converted it to the wild-type. All actions of 8-pCPT were not reproduced by its non-active analogue and abolished by Epac signalling inhibitor Brefeldin A. We propose that disturbances in cAMP homeostasis in MeCP2 -/y mice can lead to inadequate Epac signalling. Concomitant defective development of respiratory circuits may be responsible for irregular breathing activity in RTT.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232545     DOI: 10.1016/j.neuropharm.2011.01.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  16 in total

1.  β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome.

Authors:  Nikolaos Mellios; Jonathan Woodson; Rodrigo I Garcia; Benjamin Crawford; Jitendra Sharma; Steven D Sheridan; Stephen J Haggarty; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

2.  Deficiency of the purine metabolic gene HPRT dysregulates microRNA-17 family cluster and guanine-based cellular functions: a role for EPAC in Lesch-Nyhan syndrome.

Authors:  Ghiabe-Henri Guibinga; Fiona Murray; Nikki Barron; William Pandori; Gorjan Hrustanovic
Journal:  Hum Mol Genet       Date:  2013-06-25       Impact factor: 6.150

3.  CREB Signaling Is Involved in Rett Syndrome Pathogenesis.

Authors:  Qian Bu; Anxin Wang; Hamdi Hamzah; Alex Waldman; Keer Jiang; Qiping Dong; Ronghui Li; Jason Kim; Daniel Turner; Qiang Chang
Journal:  J Neurosci       Date:  2017-03-07       Impact factor: 6.167

4.  Polysomnographic findings in Rett syndrome: a case-control study.

Authors:  Marco Carotenuto; Maria Esposito; Alfredo D'Aniello; Carmen Donatella Rippa; Francesco Precenzano; Antonio Pascotto; Carmela Bravaccio; Maurizio Elia
Journal:  Sleep Breath       Date:  2012-03-07       Impact factor: 2.816

Review 5.  Breathing abnormalities in animal models of Rett syndrome a female neurogenetic disorder.

Authors:  Chun Jiang; Ningren Cui; Weiwei Zhong; Christopher M Johnson; Yang Wu
Journal:  Respir Physiol Neurobiol       Date:  2016-11-21       Impact factor: 1.931

Review 6.  cAMP and Epac in the regulation of tissue fibrosis.

Authors:  Paul A Insel; Fiona Murray; Utako Yokoyama; Silvia Romano; Hongruo Yun; Loren Brown; Aaron Snead; David Lu; Nakon Aroonsakool
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 7.  Breathing challenges in Rett syndrome: lessons learned from humans and animal models.

Authors:  Jan-Marino Ramirez; Christopher Scott Ward; Jeffrey Lorenz Neul
Journal:  Respir Physiol Neurobiol       Date:  2013-06-28       Impact factor: 1.931

8.  Spinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling.

Authors:  D P Fields; S R Springborn; G S Mitchell
Journal:  J Neurophysiol       Date:  2015-08-12       Impact factor: 2.714

9.  Epac-inhibitors: facts and artefacts.

Authors:  Holger Rehmann
Journal:  Sci Rep       Date:  2013-10-23       Impact factor: 4.379

10.  An autism-associated variant of Epac2 reveals a role for Ras/Epac2 signaling in controlling basal dendrite maintenance in mice.

Authors:  Deepak P Srivastava; Kevin M Woolfrey; Kelly A Jones; Charles T Anderson; Katharine R Smith; Theron A Russell; Hyerin Lee; Marina V Yasvoina; David L Wokosin; P Hande Ozdinler; Gordon M G Shepherd; Peter Penzes
Journal:  PLoS Biol       Date:  2012-06-26       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.